Naturally Occurring Neomorphic PIK3R1 Mutations Activate the MAPK Pathway, Dictating Therapeutic Response to MAPK Pathway Inhibitors
Cancer Cell - United States
doi 10.1016/j.ccell.2014.08.017
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2014
Authors
Publisher
Elsevier BV